-
Kenya-US rare earths deal challenged in court over secrecy
-
Sinner, Djokovic set to start Wimbledon title charge
-
Santner strikes as New Zealand eye England series win
-
Pakistan launches deadliest attack on Afghanistan in months
-
Broos may change decision to quit as South Africa coach
-
Strauss 'dumbfounded' by timing of Stokes's England exit
-
French swim star Marchand suffers injury scare before Europeans
-
Monza turn to Juric for return to Serie A
-
France skipper Dupont to miss Nations Championship
-
Stocks mixed, oil edges up after US-Iran clashes
-
Springbok milestones loom for Willemse and Kolbe against England
-
Catholic traditionalists risk schism in Church
-
Tennis players end Wimbledon prize-money protest
-
Europe's deadly heatwave scorches eastern flank, takes aim at Ukraine
-
Pogacar rides with Del Toro and Yates in quest for fifth Tour de France
-
PSG in talks with Leipzig to buy Ivory Coast star Diomande
-
Australia to host Brazil double-header after World Cup
-
Venezuela search teams scramble as hope fades of finding quake survivors
-
Stocks rise and oil edges up as US, Iran call end to latest attacks
-
Bondi Beach attack survivor tells of 'trauma' of online AI images
-
South Korea to invest nearly $1.2 tn in chips, AI data centres
-
Pakistan strikes on eastern Afghanistan kill dozens
-
Russia rallies support for army with 'patriotic' tourist routes
-
Cape Verde, Africa's outlier in LGBTQ tolerance
-
Brazil, Germany eye World Cup last 16 as Netherlands face Morocco
-
South Korea demands change after dismal World Cup exit
-
Washington says US, Iran pausing strikes, talks to proceed
-
Stocks mixed and oil rises as US, Iran call end to latest attacks
-
EU, China trade tensions loom over minister visit
-
For sale on Facebook: monkeys, rhino horn and dead pangolins
-
Israelis, Palestinians torn over sacred shrine in city of Hebron
-
In Sudan's Kordofan, a key city reels as paramilitary offensive looms
-
Scheffler to face Hovland in Monday playoff for PGA Travelers title
-
Ryu Hae-ran wins Women's PGA Championship
-
'Burnt out' Stokes leaves England facing tricky questions
-
Germany must win to defy World Cup doubters, says Nagelsmann
-
Critical rescue window closing in Venezuela as quake death toll nears 1,500
-
NuRAN Wireless Is Now SEC-Registered - 40-F Declared Effective, Nasdaq Listing One Step Closer
-
Lara Exploration Announces 14,000 Metre Validation Drilling Program Underway at the Planalto Project
-
Genflow Biosciences PLC Announces Result of AGM
-
Noram Lithium Engages Triforce Media Inc. to Support Corporate Communications Strategy
-
Eco Minerals Announces Confidential Submission of a Draft Registration Statement for a Proposed Initial Public Offering
-
Ur-Energy Receives Final WDEQ Authorization to Transport Uranium-Loaded Resin from Shirley Basin to Lost Creek
-
NOVARION Systems showcases NOVARA
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - June 29
-
How to Start a Functional Beverage Brand: Free FMCG Webinar
-
HM Exploration Discovers New Blind Massive Sulphide Lens at Lewis Pilley's Project
-
Aclara Introduces Super Pure Rare Earth Carbonate ("SPREC")
-
Pivotree Inc. Announces Results from Its Annual and Special Meeting of Shareholders
-
Who is the Best Facial Plastic Surgeon in Seattle?
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
LAVAL, QC / ACCESS Newswire / February 14, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that it will participate in the 2025 J.P. Morgan Global Leveraged Finance Conference in Miami Beach, Florida on February 24. A live audio webcast of the event will be accessible on the Investor Relations section of Bausch Health's website.
Details
Date: | Monday, February 24, 2025 |
Time: | 8:45 a.m. U.S. EST |
Webcast: |
A replay of the event will be available on the investor relations website following the event.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may generally be identified by the use of the words "will," "anticipates," "hopes," "expects," "intends," "plans," "should," "could," "would," "may," "believes," "subject to" and variations or similar expressions. These statements are neither historical facts nor assurances of future performance, are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Actual results are subject to other risks and uncertainties that relate more broadly to Bausch Health's overall business, including those more fully described in Bausch Health's most recent annual and quarterly reports and detailed from time to time in Bausch Health's other filings with the U.S. Securities and Exchange Commission and the Canadian Securities Administrators, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. These forward-looking statements speak only as of the date hereof. The Company undertakes no obligation to update any of these forward-looking statements to reflect events, information or circumstances after the date of this news release or to reflect actual outcomes, unless required by law.
Investor Contact: | Media Contact: |
SOURCE: Bausch Health Companies Inc.
View the original press release on ACCESS Newswire
A.Clark--AT